Description
রেজিস্টার্ড চিকিৎসকের পরামর্শ মোতাবেক ঔষধ সেবন করুন
Indications:
Vibose 0.2mg is indicated for the treatment of type 2 diabetes mellitus, particularly for controlling postprandial hyperglycemia, as monotherapy or in combination with other anti-diabetic agents.
Pharmacology:
Vibose contains Acarbose, an alpha-glucosidase inhibitor that delays carbohydrate digestion and absorption in the intestine, leading to a smaller rise in blood glucose after meals.
Dosage & Administration:
The usual starting dose is 25 mg once daily with the first bite of a main meal. Dosage may be gradually increased up to 0.2 mg three times daily depending on patient tolerance and blood glucose levels. Taken with meals.
Interaction:
May interact with digestive enzyme preparations (e.g., amylase), intestinal adsorbents, and antacids. Risk of hypoglycemia when combined with insulin or sulfonylureas.
Contraindications:
Contraindicated in patients with hypersensitivity to Acarbose, inflammatory bowel disease, colonic ulceration, partial intestinal obstruction, or chronic digestive disorders.
Side Effects:
Common side effects include flatulence, abdominal discomfort, and diarrhea. Rarely, liver enzyme elevations or hypersensitivity reactions may occur.
Pregnancy & Lactation:
Use only if clearly needed and prescribed by a physician. Safety during pregnancy or lactation has not been fully established.
Precautions & Warnings:
Regular monitoring of liver enzymes is recommended during treatment. Not effective in treating type 1 diabetes or diabetic ketoacidosis.
Therapeutic Class:
Alpha-glucosidase inhibitors
Storage Conditions:
Store in a cool and dry place below 30°C. Protect from light and moisture. Keep out of reach of children.
.jpg)
 10025 100 MG 25 MG.jpg)
 100 IU.jpg)
.jpg)
 15050160.jpg)
 60 ML.jpg)
 350ML.jpg)
 400MG.jpg)
 350ML.jpg)
 100 IU.jpg)
 30PCS.jpg)
 20025 20025.jpg)
Change Language